Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-25

Clinical Trial Update: Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure® and the Restylane® Range [Phase 3]

View source ↗

Summary

Phase 3 trial reporting subject satisfaction after facial aesthetic treatment with Azzalure and Restylane products; completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azzalure
  • Restylane (hyaluronic acid dermal filler)

Snippet

Sponsor: Galderma R&D | Conditions: Aging | Phase 3 | Status: COMPLETED | Results posted: 2014-04-25